These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 38702615

  • 1. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Jiang H, Liu Y, Guo H, Liu Z, Li Z.
    BMC Cardiovasc Disord; 2024 May 03; 24(1):234. PubMed ID: 38702615
    [Abstract] [Full Text] [Related]

  • 2. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y.
    Cardiovasc Diabetol; 2021 Jul 08; 20(1):137. PubMed ID: 34238294
    [Abstract] [Full Text] [Related]

  • 3. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Guo X, Shen R, Yan S, Su Y, Ma L.
    Cardiovasc Diabetol; 2023 Mar 02; 22(1):43. PubMed ID: 36864455
    [Abstract] [Full Text] [Related]

  • 4. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis.
    Liang S, Wang C, Zhang J, Liu Z, Bai Y, Chen Z, Huang H, He Y.
    Cardiovasc Diabetol; 2023 Jul 06; 22(1):170. PubMed ID: 37415168
    [Abstract] [Full Text] [Related]

  • 5. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
    Chen Q, Xiong S, Zhang Z, Yu X, Chen Y, Ye T, Yang S, Qi L, Chen X, Liu H, Zheng J, Cai L.
    Cardiovasc Diabetol; 2023 Oct 21; 22(1):284. PubMed ID: 37865753
    [Abstract] [Full Text] [Related]

  • 6. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ.
    Coron Artery Dis; 2015 Jan 21; 26(1):5-10. PubMed ID: 25211654
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
    Chen Q, Xiong S, Ye T, Gao Y, Wang J, Li X, Li Y, Cui C, Liu H, Zhang Z, Cai L, Zheng J.
    Cardiovasc Diabetol; 2024 May 16; 23(1):172. PubMed ID: 38755609
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Tao S, Yu L, Li J, Xie Z, Huang L, Yang D, Tan Y, Zhang W, Huang X, Xue T.
    Cardiovasc Diabetol; 2023 Nov 28; 22(1):322. PubMed ID: 38017540
    [Abstract] [Full Text] [Related]

  • 9. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
    Baktashian M, Saffar Soflaei S, Kosari N, Salehi M, Khosravi A, Ahmadinejad M, Moohebati M, Ebrahimi M, Rahmani F, Khameneh-Bagheri R, Ahmadi M, Sadabadi F, Tayefi M, Bazhdanzadeh S, Ferns GA, Hashemi SM, Pasdar A, Ghayour-Mobarhan M.
    Cardiovasc Revasc Med; 2019 Jul 28; 20(7):583-587. PubMed ID: 30232022
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) and long-term in-stent restenosis after percutaneous coronary intervention.
    Mahmoud AK, Farina JM, Awad K, Ali NB, Pereyra M, Scalia IG, Abbas MT, Allam MN, Kamel MA, Abu Rmilah AA, Chao CJ, Barry T, Alsidawi S, Lester SJ, Pollak PM, Alkhouli MA, Lee KS, Yang EH, Lee RW, Sweeney JP, Fortuin DF, Ayoub C, Arsanjani R.
    Eur J Prev Cardiol; 2024 Nov 11; 31(15):1878-1887. PubMed ID: 38916491
    [Abstract] [Full Text] [Related]

  • 11. Triglyceride-glucose index as a predictor of cardiac adverse events in acute coronary syndrome patients undergoing percutaneous coronary intervention: role of diabetes.
    Khalaji A, Behnoush AH, Pasebani Y, Rafati A, Mahmoodi T, Arzhangzadeh A, Shamshiri Khamene S, MohammadKhawajah I, Mehrani M, Vasheghani-Farahani A, Masoudkabir F, Najafi K, Askari MK, Harrison A, Nelson JR, Hosseini K, Hernandez AV.
    BMC Cardiovasc Disord; 2024 Sep 27; 24(1):514. PubMed ID: 39333881
    [Abstract] [Full Text] [Related]

  • 12. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
    Qin Z, Zhou K, Li YP, Wang JL, Cheng WJ, Hu CP, Shi C, He H, Zhou YJ.
    Cardiovasc Diabetol; 2019 Jan 28; 18(1):11. PubMed ID: 30691501
    [Abstract] [Full Text] [Related]

  • 13. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
    Song T, Fu Y, Wang Y, Li W, Zhao J, Wang X, Wang H, Zhao Y, Fu X.
    BMC Cardiovasc Disord; 2021 Jan 07; 21(1):24. PubMed ID: 33413149
    [Abstract] [Full Text] [Related]

  • 14. Association between oral infections, triglyceride-glucose index, and in-stent restenosis.
    Wu Y, Du L, Fan M, Chen X, Tang Y, Wang Y, Wang K, Wang S, Li G.
    Oral Dis; 2023 Nov 07; 29(8):3698-3706. PubMed ID: 36321885
    [Abstract] [Full Text] [Related]

  • 15. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C, De Cecco CN, Vliegenthart R, Duguay TM, Stubenrauch AC, Rosenberg RD, Varga-Szemes A, Bayer RR, Yang J, Ebersberger U, Baquet M, Jochheim D, Hoffmann E, Steinberg DH, Chiaramida SA, Schoepf UJ.
    J Cardiovasc Comput Tomogr; 2016 Nov 07; 10(5):377-83. PubMed ID: 27431607
    [Abstract] [Full Text] [Related]

  • 16. Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.
    Komatsu T, Yaguchi I, Komatsu S, Nakahara S, Kobayashi S, Sakai Y, Taguchi I.
    Tex Heart Inst J; 2015 Aug 07; 42(4):327-32. PubMed ID: 26413014
    [Abstract] [Full Text] [Related]

  • 17. Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention.
    Yang CD, Shen Y, Lu L, Yang ZK, Hu J, Zhang RY, Shen WF, Ding FH, Wang XQ.
    Cardiovasc Diabetol; 2020 Sep 04; 19(1):133. PubMed ID: 32887588
    [Abstract] [Full Text] [Related]

  • 18. The impact of triglyceride-glucose index on the prognosis of post-PCI patients-a meta-analysis.
    Wang YF, Kong XH, Tao HM, Tao L.
    Front Cardiovasc Med; 2024 Sep 04; 11():1396865. PubMed ID: 38952542
    [Abstract] [Full Text] [Related]

  • 19. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X.
    Cardiovasc Diabetol; 2020 Mar 10; 19(1):31. PubMed ID: 32156279
    [Abstract] [Full Text] [Related]

  • 20. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C.
    Cardiovasc Diabetol; 2019 Nov 13; 18(1):150. PubMed ID: 31722708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.